Although increased priming correlated with increased sensitivity to BCL-2/BCL-xL inhibition in certain contexts, TIS cancer cells generally exhibited similar or reduced overall priming compared to their proliferative counterparts, revealing a nuanced apoptotic landscape. Here, BCL2 is linked to cancer.